Similar Items: Evaluation of the costs of managing cutaneous adverse drug reactions to first-line TB therapy in South African TB patients
- Mechanisms of resistance to new generation anti-TB drugs
- Bio-profiling of TB patients with and without Type 2 Diabetes before and during anti-tuberculosis drug (ATD) therapy
- Patient experiences and perceptions of non-compliance with TB treatment
- Immunological markers for active TB and early treatment response indicators
- Molecular characterization and drug susceptibility of isolates from MDR-TB patients in the Eastern Cape and North West provinces of South Africa
- Evaluating TB treatment responses by [18F]FDG-PET/CT imaging